Annual ROE:
8.05%+4.54%(+129.34%)Summary
- As of today, BMRN annual return on equity is 8.05%, with the most recent change of +4.54% (+129.34%) on December 31, 2024.
- During the last 3 years, BMRN annual ROE has risen by +9.58% (+626.14%).
- BMRN annual ROE is now -91.60% below its all-time high of 95.88%, reached on December 31, 2005.
Performance
BMRN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
11.66%+2.04%(+21.21%)Summary
- As of today, BMRN quarterly return on equity is 11.66%, with the most recent change of +2.04% (+21.21%) on June 30, 2025.
- Over the past year, BMRN quarterly ROE has increased by +6.53% (+127.29%).
- BMRN quarterly ROE is now -98.45% below its all-time high of 753.35%, reached on March 31, 2005.
Performance
BMRN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
BMRN ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1Y1 Year | +129.3% | +127.3% |
3Y3 Years | +626.1% | +832.8% |
5Y5 Years | +1132.0% | +198.2% |
BMRN ROE Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
---|---|---|---|---|---|
3Y | 3-Year | at high | +626.1% | at high | +638.0% |
5Y | 5-Year | -66.1% | +626.1% | -54.2% | +867.1% |
All-Time | All-Time | -91.6% | +101.1% | -98.5% | +102.6% |
BMRN ROE History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | 11.66%(+21.2%) |
Mar 2025 | - | 9.62%(+18.9%) |
Dec 2024 | 8.05%(+129.3%) | 8.09%(+28.6%) |
Sep 2024 | - | 6.29%(+22.6%) |
Jun 2024 | - | 5.13%(+21.6%) |
Mar 2024 | - | 4.22%(+20.2%) |
Dec 2023 | 3.51%(+10.0%) | 3.51%(+12.1%) |
Sep 2023 | - | 3.13%(+44.9%) |
Jun 2023 | - | 2.16%(+36.7%) |
Mar 2023 | - | 1.58%(-50.2%) |
Dec 2022 | 3.19%(+308.5%) | 3.17%(+66.0%) |
Sep 2022 | - | 1.91%(+52.8%) |
Jun 2022 | - | 1.25%(+35.9%) |
Mar 2022 | - | 0.92%(+160.5%) |
Dec 2021 | -1.53%(-106.4%) | -1.52%(-500.0%) |
Sep 2021 | - | 0.38%(-98.2%) |
Jun 2021 | - | 21.14%(-0.0%) |
Mar 2021 | - | 21.15%(-12.6%) |
Dec 2020 | 23.77%(+3147.4%) | 24.19%(-5.0%) |
Sep 2020 | - | 25.47%(+551.4%) |
Jun 2020 | - | 3.91%(+5.1%) |
Mar 2020 | - | 3.72%(+570.9%) |
Dec 2019 | -0.78%(+70.8%) | -0.79%(+44.8%) |
Sep 2019 | - | -1.43%(+62.0%) |
Jun 2019 | - | -3.76%(-22.1%) |
Mar 2019 | - | -3.08%(-14.9%) |
Dec 2018 | -2.67%(+36.4%) | -2.68%(+39.0%) |
Sep 2018 | - | -4.39%(+0.7%) |
Jun 2018 | - | -4.42%(+14.7%) |
Mar 2018 | - | -5.18%(-23.6%) |
Dec 2017 | -4.20%(+82.8%) | -4.19%(+26.1%) |
Sep 2017 | - | -5.67%(+19.3%) |
Jun 2017 | - | -7.03%(+69.1%) |
Mar 2017 | - | -22.74%(+13.2%) |
Dec 2016 | -24.39%(-178.7%) | -26.21%(-28.5%) |
Sep 2016 | - | -20.39%(+12.5%) |
Jun 2016 | - | -23.29%(-192.6%) |
Mar 2016 | - | -7.96%(-1.9%) |
Dec 2015 | -8.75%(+6.3%) | -7.81%(+49.1%) |
Sep 2015 | - | -15.34%(-34.4%) |
Jun 2015 | - | -11.41%(-17.1%) |
Mar 2015 | - | -9.74%(-6.1%) |
Dec 2014 | -9.34%(+37.6%) | -9.18%(-2.6%) |
Sep 2014 | - | -8.95%(+34.8%) |
Jun 2014 | - | -13.73%(-3.5%) |
Mar 2014 | - | -13.26%(+7.7%) |
Dec 2013 | -14.97%(-17.1%) | -14.36%(+0.2%) |
Sep 2013 | - | -14.39%(-33.2%) |
Jun 2013 | - | -10.80%(+16.1%) |
Mar 2013 | - | -12.88%(-3.1%) |
Dec 2012 | -12.78%(-77.0%) | -12.49%(-22.9%) |
Sep 2012 | - | -10.16%(+17.9%) |
Jun 2012 | - | -12.38%(-27.2%) |
Mar 2012 | - | -9.73%(-34.4%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | -7.22%(-118.2%) | -7.24%(-30.2%) |
Sep 2011 | - | -5.56%(-117.7%) |
Jun 2011 | - | 31.37%(-14.4%) |
Mar 2011 | - | 36.66%(-16.9%) |
Dec 2010 | 39.60%(>+9900.0%) | 44.10%(-24.0%) |
Sep 2010 | - | 58.00%(+1459.1%) |
Jun 2010 | - | 3.72%(-17.7%) |
Mar 2010 | - | 4.52%(+2758.8%) |
Dec 2009 | -0.16%(-101.2%) | -0.17%(-102.4%) |
Sep 2009 | - | 7.02%(+35.0%) |
Jun 2009 | - | 5.20%(-20.4%) |
Mar 2009 | - | 6.53%(-51.8%) |
Dec 2008 | 13.28%(+228.4%) | 13.55%(+215.1%) |
Sep 2008 | - | 4.30%(+190.5%) |
Jun 2008 | - | 1.48%(+155.4%) |
Mar 2008 | - | -2.67%(+72.6%) |
Dec 2007 | -10.34%(+92.7%) | -9.73%(+49.5%) |
Sep 2007 | - | -19.26%(+21.8%) |
Jun 2007 | - | -24.62%(+12.3%) |
Mar 2007 | - | -28.07%(+49.4%) |
Dec 2006 | -141.46%(-247.5%) | -55.43%(+75.2%) |
Sep 2006 | - | -223.39%(-164.4%) |
Jun 2006 | - | 346.84%(+191.8%) |
Mar 2006 | - | 118.86%(+37.4%) |
Dec 2005 | 95.88%(+112.8%) | 86.48%(-49.0%) |
Sep 2005 | - | 169.68%(-30.7%) |
Jun 2005 | - | 244.72%(-67.5%) |
Mar 2005 | - | 753.35%(+265.6%) |
Dec 2004 | -751.65%(-967.1%) | -454.96%(-189.5%) |
Sep 2004 | - | -157.17%(-44.8%) |
Jun 2004 | - | -108.55%(-96.3%) |
Mar 2004 | - | -55.30%(+0.4%) |
Dec 2003 | -70.44%(-18.6%) | -55.51%(-9.1%) |
Sep 2003 | - | -50.90%(-5.3%) |
Jun 2003 | - | -48.33%(+9.9%) |
Mar 2003 | - | -53.66%(+8.8%) |
Dec 2002 | -59.38%(-20.7%) | -58.86%(+17.8%) |
Sep 2002 | - | -71.64%(-3.1%) |
Jun 2002 | - | -69.49%(+8.3%) |
Mar 2002 | - | -75.82%(-8.3%) |
Dec 2001 | -49.18%(-13.8%) | -69.99%(-29.4%) |
Sep 2001 | - | -54.08%(-7.1%) |
Jun 2001 | - | -50.51%(-13.1%) |
Mar 2001 | - | -44.67%(-3.5%) |
Dec 2000 | -43.21%(-2.3%) | -43.18%(+5.8%) |
Sep 2000 | - | -45.85%(+14.5%) |
Jun 2000 | - | -53.60%(+16.9%) |
Mar 2000 | - | -64.50%(+2.4%) |
Dec 1999 | -42.25%(+28.6%) | -66.10%(+3.3%) |
Sep 1999 | - | -68.38%(-59.0%) |
Jun 1999 | - | -43.01%(-177.3%) |
Mar 1999 | - | -15.51% |
Dec 1998 | -59.20%(-108.2%) | - |
Dec 1997 | -28.43% | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual return on equity?
- What is the all-time high annual ROE for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual ROE year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly ROE year-on-year change?
What is BioMarin Pharmaceutical Inc. annual return on equity?
The current annual ROE of BMRN is 8.05%
What is the all-time high annual ROE for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual return on equity is 95.88%
What is BioMarin Pharmaceutical Inc. annual ROE year-on-year change?
Over the past year, BMRN annual return on equity has changed by +4.54% (+129.34%)
What is BioMarin Pharmaceutical Inc. quarterly return on equity?
The current quarterly ROE of BMRN is 11.66%
What is the all-time high quarterly ROE for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly return on equity is 753.35%
What is BioMarin Pharmaceutical Inc. quarterly ROE year-on-year change?
Over the past year, BMRN quarterly return on equity has changed by +6.53% (+127.29%)